Targeting the Sarcomere: Myosin Inhibitors as the Revolutionary Game Changer in Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy (HCM) represents the most common inherited cardiac disease and a leading cause of heart failure, arrhythmias, and sudden cardiac death in young individuals. For decades, management of HCM has relied on symptom control with β-blockers, calcium channel blockers, disopyramid...
Збережено в:
| Автори: | , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
IMR Press
2026-01-01
|
| Серія: | Reviews in Cardiovascular Medicine |
| Предмети: | |
| Онлайн доступ: | https://www.imrpress.com/journal/RCM/27/1/10.31083/RCM47341 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|